We analyzed one assertion on whether blocking CCK-A receptors prevents fat-induced satiety in humans, and the evidence we’ve reviewed so far supports this idea. In a study involving healthy young adults, a drug called loxiglumide was used to block CCK-A receptors — these are proteins in the gut that respond to signals from fat digestion. When these receptors were blocked, participants did not feel as full after eating fat, even though their bodies were digesting it normally. This suggests that CCK-A receptor activity plays a role in the body’s normal response to dietary fat and the feeling of fullness that follows [1].
We did not find any studies that contradicted this finding. The single piece of evidence we reviewed shows that when CCK-A receptors are turned off, the usual signal for fullness after fat intake is reduced or absent. This does not mean CCK-A receptors are the only way the body senses fullness — other signals from the gut and brain likely still work. But in this specific case, blocking these receptors appears to interfere with the expected response to fat.
The evidence we’ve reviewed so far leans toward the idea that CCK-A receptors are needed for fat to trigger satiety in humans. However, this conclusion is based on only one study, and we don’t yet know how this applies to older adults, people with metabolic conditions, or over repeated meals. More research would be needed to understand how consistent this effect is across different people and situations.
In everyday terms: if your body relies on CCK-A receptors to tell you you’re full after eating fatty food, blocking them might make you feel less satisfied — which could lead to eating more. But this is just one observation from one group of people, and we don’t yet know how it plays out in real life.
0 items of evidenceView full answer